US FDA okays electronic submission of authorised generics info
This article was originally published in Scrip
Executive Summary
The US FDA will allow NDA holders to electronically submit certain information regarding authorised generics under a final rule that takes effect on January 25th. The method of submission is a change from an earlier proposal, which required the information be sent to the agency either by regular mail or courier.